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1. INTRODUCTION 
Treatment of cells with interferon (IFN) results 
in the induction of an enzyme, (2’-5’)-oligoadeny- 
late synthetase, which in the presence of double- 
stranded RNA catalyzes the polymerization of 
ATP into a series of oligonucleotides with the uni- 
que linkage of (2’-5 ‘)-phosphodiester [11. These 
(2’-5’)-oligoadenylate molecules activate an en- 
donuclease, RNase F, which is present in both 
IFN-treated and untreated cells [2-51. Activation 
of RNase F has been implicated in both the antivi- 
ral and anticellular activities of IFN [6,7]. Several 
groups have studied the specificity of interaction 
between (2’-5’)-oligoadenylate derivatives and 
RNase F. Oligomers of three or more adenylate 
residues, containing di- or tri-phosphate at the 
5 ‘-end, were able to bind and activate RNase F 
with similar efficiencies. Oligomers with mono- 
phosphate at the 5 ‘-end bind RNase F, while de- 
phosphorylated molecules could neither bind nor 
activate it [3,8,9,15]. 
[ 111. Extensive degradation of polyadenylate pro- 
duct with the nucleases PI or T2 produced 5 ’ and 
3 ’ AMP, respectively. The polyadenylate (average 
sedimentation coefficient of 3 S) was taken for 
partial hydrolysis by P1 nuclease [13]. 
Degradation products were resolved according 
to charge on a DEAE-cellulose column with a salt 
gradient (0.02-0.65 M ammonium bicarbonate). 
Oligonucleotides in the range l-7 residues are well 
separated on this column. The oligonucleotide 
fractions were collected and further characterized 
by high-voltage paper electrophoresis and paper 
chromatography. 
Here, we extend these studies and examine the 
role of the 2’-5’-phosphodiester linkage in the ac- 
tivation of the RNase F. 
2. MATERIALS AND METHODS 
2.1. Preparation of (3 ‘-5 ‘)-ppApApA 
Polyadenylate was synethesized by enzymatic 
polymerization of ADP with Micrococcus IJ~SO- 
deikticus polynucleotide phosphorylase [121 and 
the (3 ‘-5 ‘)-polyadenylate product was purified 
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Characterization was carried out before and 
after treatment with Escherichia coli alkaline phos- 
phatase. The fraction containing (3 ’ -5 ’ )-pApApA 
was taken and salt was removed by repeated lyo- 
phylization. The yield of trinucleotide was 10% of 
the input polyadenylate. The purified (3 ‘-5 ‘)- 
pApApA (5000 A& was phosphorylated at the 
5’-end with the tri-n-butyl-ammonium salt of 
phosphoric acid as in [14]. Yields of phosphoryla- 
tion of several preparations were -20%. The pro- 
ducts of this reaction were fractionated on a DEAE- 
cellulose column with a salt gradient (0.02-0.65 M 
ammonium bicarbonate). Two main peaks were re- 
solved by this column. The first eluting material 
was identified as pApApA by paper chromato- 
graphy and electrophoresis as above. Both peaks 
were further characterized by chromatography on 
thin-layer plates of poly(ethyleneimine)-cellulose 
[ 151 and high-pressure liquid chromatography 
(HPLC) (see fig. 1). 
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2.2. Preparation of (2 ‘-5 ‘)-ppApApA 
For the synthesis of (2’-5 I)-pApApA, we fol- 
lowed the procedure in [lo]. In brief, (2’-3’)- 
cyclic AMP was polymerized as in [ 191 and the 
polymer obtained was digested with P, nuclease 
under conditions for a complete cleavage of 
(3’-5 ‘)-phosphodiester bonds [lo]. Digestion pro- 
ducts were resolved on a DEAE-cellulose column 
and characterized as in [IO] and above. Fractions 
containing (2 ‘-5 ‘)-pApApA were collected and 
chemical phosphorylation of (2’-5’)-pApApA 
was conducted in parallel with (3’-5’)-pApApA. 
Purification and analysis of the two isomers were 
carried out by the same method. 
3. RESULTS 
The oligonucleotide (3 ‘-5’)-pApApA was syn- 
thesized by enzymatic polymerization of ADP with 
polynucleotide phosphorylase [11,121, followed by 
partial degradation with P, nuclease [13], and puri- 
fication of trinucleotide containing 5’ phospho- 
monoester. (2’-5 ‘)-pApApA was synthesized by 
chemical polymerization of (2’-3 ‘)-cyclic adeno- 
sine monophosphate [ 10,191, followed by cleavage 
of all (3 ‘-5 ‘)-phosphodiester bonds with PI 
nuclease [lo]. The two isomers of pApApA were 
chemically phosphorylated to produce the final 
products ppApApA. Both isomers were analyzed 
by chromatography on thin-layer plates of 
poly(ethyleneimine)-cellulose [ 151 and by HPLC, 
before and after digestions with alkaline phospha- 
tase and P, nuclease. The two compounds appear- 
ed to be homogenous and of the expected struc- 
ture. The analysis of (3 ‘-5 ‘)-ppApApA by HPLC 
is illustrated in fig. 1, the compound eluted from 
the column as a single peak (fig. 1A). Digestion of 
(3’-5’)-ppApApA with P, nuclease resulted in 
two products which eluted from the HPLC as ex- 
pected at the positions of A5 ’ p (4.3 min) and 
AS’pp (3.6 min) (fig. 1B). 
To study the specificity involved in the activa- 
tion of RNase F, the oligoadenylate derivatives 
were co-precipitated with calcium phosphate and 
added to tissue cultured L-cells. This procedure 
enabled efficient penetration of oligonucleotides 
into the cytoplasm and inhibition of cell protein 
synthesis by RNase F activation [6]. Introduction of 
(3 ‘-5 ‘)-ppApApA into cells resulted in the inhibi- 
tion of protein synthesis; 50% inhibition was ob- 
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Fig. 1. Analysis of (3’-5 ‘)-ppApApA by HPLC. Chro- 
matography was carried out on C-18 column as in [9]. 
Compounds were eluted with 5 min wash with buffer A 
(50 mM ammonium phosphate, pH 7.0) at 1 ml/min, a 
25 min gradient from buffer A (80%) to 20% methanol :
water (1: 1); 5 min gradient from buffer A (50%) to 50% 
methanol: water (1: 1) and a 5 min gradient from buffer 
A (30%) to 70% methanol: water (1 : 1). 
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Fig. 2. Activation of RNase F by different derivatives of 
oligoadenylate. Oligonucleotides were synthesized as in 
section 2. The calcium phosphate co-precipitation tech- 
nique was described in [6,16]. L929 cells (1 x 105) were 
seeded in plates with 24 wells (16 mm) in 1 ml RPM1 1640 
medium containing 10% calf serum; 48 h after seeding, 
cultures were incubated with the oligonucleotides co-pre- 
cipitated with calcium phosphate for 2 h at 37°C [16]. 
The precipitates were removed and cultures were incu- 
bated for another 2 h in 1 ml Eagle’s (MEM) medium 
containing 10% calf serum. Cells were pulse labeled for 
1 h with [3H]leucine (2&i/0.5 ml MEM medium minus 
leucine) and protein synthesis was assayed as [16]. The 
results were determined from the replication in an aver- 
age of three wells. L-cells without oligonucleotide (100%) 
incorporated 108000 cpm: (2’-5’)-ppApApA (U); 
(3’-5’)-ppApApA (o-_-o); (2’-5’)-pApApA (M); 
(3’-5’)-pApApA (W); (2’-5’)-ApApA (H); 
(3’-5’)-ApApA ([1---o). 
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tained at 4 x 10M6 M (fig. 2). Under the same con- 
ditions, the isomer (2’-5’)-ppApApA inhibited 
protein synthesis by 50% at 8 x lo-’ M. 
These results indicated that, while (3 ‘-5 ‘)- 
ppApApA could activate RNase F in cells, 
the activation required 5-lo-fold higher con- 
centrations than those of the natural compound 
(2 ‘-5 ‘)-ppApApA. The monophosphate precur- 
sors, (2’-5 ‘)-pApApA and (3 ‘-5 ‘)-pApApA, did 
not affect protein synthesis after introduction into 
cells. The dephosphorylated isomers (3 ‘-5 ‘)- 
ApApA and (2’-5’)-ApApA, were also inactive in 
these cells (fig. 2). In the assay system described 
above, the enzymatically prepared (2’-5 ‘)- 
pppA(pA), (where n = 2-5) [20], inhibited protein 
synthesis by 50% at 5 x lo-’ M (not shown). 
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Fig. 3. Kinetics of cellular protein synthesis after treat- 
ment with (3 ‘-5 ‘)- and (2’-5 ‘)-ppApApA. L-cells were 
treated with (2’-5’)-ppApApA 5 x lo-’ M (X-X), or 
(3’-5’)-ppApApA 5 x lo-6 M (u), as in fig. 2. 
After incubation for 2 h with calcium phosphate precipi- 
tates, the cultures were washed and MEM medium con- 
taining 10% calf serum was added. At various times 
after the addition of calcium phosphate precipitates, the 
rate of protein synthesis was assayed by t3H]leucine in- 
corporation for 15 min. For the 1 h point, cultures were 
treated with calcium phosphate for 1 h only, washed and 
pulse labeled for 15 min. Control cultures treated with 
calcium phosphate but without oligonucleotides were as- 
sayed in parallel at each time point, and the percentage 
of [3H]leucine incorporated was calculated by taking 
the incorporation without oligonucleotide at each time 
point as 100%. In this way, the slight inhibitory effect of 
the calcium phosphate treatment was taken into account. 
[3H]leucine incorporation at zero time before addition 
of the calcium phosphate precipitate (100%) was 34000 
cpm. 
To compare the rates of action of the two iso- 
mers, we studied the kinetics of protein synthesis 
inhibited by the two active compounds. When 
(3 ‘-5 ‘)-ppApApA was added to cells at a lo- 
fold higher concentration than that of (2’-5’)- 
ppApApA, similar kinetics of inhibition were 
observed (fig. 3). Inhibition of 50% was noticed 
2-3 h after addition of the two isomers coprecipi- 
tated with calcium phosphate. 
Inhibition of cell protein synthesis is an indirect 
measurement of RNase F activation and RNA 
degradation. To directly assess activation of RNase 
F, by (3’-5 ‘)-ppApApA and to determine the 
(3’5’)A (2’5’)A 
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Fig. 4. Ribosomal RNA cleavage in (2’-5’)-ppApApA 
and (3 ‘-5 ‘)-ppApApA treated cells. L-cells (20 x lo6 in 
150 mm plates) were treated with oligonucleotides co- 
precipitated with calcium phosphate (see fig. 2). After 
2 h incubation, the precipitates were removed, cultures 
were washed, and MEM medium with 10% calf serum 
was added for 2 h. Cultures were washed with cold phos- 
phate-buffered saline (PBS) and cells lysed by adding 
buffer A (10 mM Hepes, pH 7.6; 15 mM Mg(Ac)z; 
90 mM KCl, 0.5% Nonidet P40). Nuclei were removed 
by centrifugation for 10 min at 8000 x g and RNA was 
purified from the cytoplasmic fraction by phenol extrac- 
tion and ethanol precipitation. RNA, after denaturation 
with glyoxal, was resolved on agarose gels (1.8%) as in 
[17] and stained with ethidium bromide: (1) control cells 
not treated with calcium phosphate; (2,3) cells treated 
with (3’-5’)-ppApApA, 5 x 10m6 and 5 x lo-’ M, 
respectively; (4,5) cells treated with (2’-5’)-ppApApA, 
10e6 and lo-’ M, respectively; (6) control cells treated 
with calcium phosphate without oligonucleotide. 
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specificity of its action, we analyzed the degrada- Dr D. Wreschner for the stimulating discussions. 
tion of ribosomal RNA which followed introduc- G.A. was supported by the Foundation for Ab- 
tion of the oligonucleotides into cells. sorption in Science. 
Activation of RNase F by (2’-5 ‘)-pppApApA 
has been shown to produce a typical pattern of 
rRNA degradation which could be resolved by 
electrophoresis on agarose gels [ 171. Introduction 
of (3 ‘-5 ’ )-ppApApA and (2 ‘-5 ‘)-ppApApA into 
L-cells activated identical patterns of rRNA cleav- 
age. However, -IO-fold higher concentrations of 
(3 ‘-5 ’ )-ppApApA than of (2’-5 ‘)-ppApApA 
were needed to obtain a similar extent of rRNA 
degradation (fig. 4). The pattern of rRNA cleav- 
ages obtained in this work after addition of 
(2’-5’)- and (3’-5’)-ppApApA was very similar, 
if not identical, to that reported for the activation 
of RNase F in L-cells by the enzymatically synthe- 
sized (2’-5’)-pppApApA [17]. 
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